51 – 60 of 363
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
PET/CT imaging 2 h after injection of [18F]PSMA-1007 can lead to higher staging of prostate cancer than imaging after 1 h
- Contribution to journal › Article
-
Mark
Effect of docetaxel added to bicalutamide in Hormone-Naïve non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14)
- Contribution to journal › Article
-
Mark
A Novel Radiographic Pattern Related to Poor Prognosis in Patients with Prostate Cancer with Metastatic Spinal Cord Compression
- Contribution to journal › Article
-
Mark
Provider Perceptions of an Electronic Health Record Prostate Cancer Screening Tool
- Contribution to journal › Article
-
Mark
Screening for prostate cancer : evidence, ongoing trials, policies and knowledge gaps
- Contribution to journal › Scientific review
- 2022
-
Mark
Isolation of Circulating Tumor Cells with Acoustophoresis : Towards a biomarker assay for prostate cancer
(2022)
- Thesis › Doctoral thesis (compilation)
-
Mark
Aspects of PET-CT in prostate cancer. Protocol optimization, diagnostic accuracy, and dosimetry.
(2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
The STAT3 inhibitor GPB730 enhances the sensitivity to enzalutamide in prostate cancer cells
- Contribution to journal › Article
-
Mark
Assessing the accuracy of [18F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients
- Contribution to journal › Article
-
Mark
Lymph swelling after radical prostatectomy and pelvic lymph node dissection
- Contribution to journal › Article
